J&J: Ufff la recesión si llega tambien a la industria

Health-care giant Johnson & Johnson braced investors for its first revenue decline in 76 years in 2009, in a sign of the toll the recession is taking on what is usually one of the most resilient sectors of the economy.

The world's largest health-care products maker by sales, with businesses ranging from pharmaceuticals to medical devices, reported a 4.9% decline in revenue to $15.18 billion in the fourth quarter of 2008.

The health care firm started to show some initial symptoms of fatigue as a result of generic pharmaceuticals competition.

Mas...

"We are seeing some signs that consumers and patients are becoming more frugal," Johnson & Johnson CEO Bill Weldon said in a conference call Tuesday morning, though he added that he believed the company would still do well in the downturn.
Mas...